Adiposity and Alzheimer's disease

Current Alzheimer Research

Volumn 4, Issue 2, 2007, Pages 127-134

  Luchsinger, Jose A ^a,b,c,d,e   Mayeux, Richard ^a,b,c,d  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^c PH9E 105 ^*  (United States)

^d NONE   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; INTERLEUKIN 6; LEPTIN; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

AGING; ALZHEIMER DISEASE; BODY FAT DISTRIBUTION; BODY MASS; DIABETES MELLITUS; DISEASE ASSOCIATION; GENETIC ANALYSIS; GLUCOSE INTOLERANCE; GLYCOSYLATION; HUMAN; HYPERINSULINEMIA; OBESITY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; VALIDITY; VASCULAR DISEASE;

ADIPOSITY; ALZHEIMER DISEASE; HUMANS; OBESITY; RISK FACTORS;

EID: 34147105943     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720507780362100     Document Type: Review

References (81)

1. Ritchie K, Lovestone S. The dementias. Lancet 360:1759-66(2002).
2. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 88:1337-42(1998).
3. Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA 262:2551-6.(1989).
4. Selkoe DJ. The origins of Alzheimer disease: a is for amyloid. JAMA 283:1615-7(2000).
5. Selkoe DJ. Alzheimer's disease: genotypes, phenotypes, and treatments. Science 275:630-1.(1997).
6. Cummings JL. Alzheimer's Disease. N Engl J Med 351:56-67(2004).
7. Haan MN, Shemanski L, Jagust WJ, Manolio TA, Kuller L. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 282:40-6.(1999).
8. Peila R, Rodriguez BL, Launer LJ, Honolulu-Asia Aging S. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 51:1256-62(2002).
9. Luchsinger JA, Tang M-X, Shea S, Mayeux R. Hyperinsulinemia and risk of Alzheimer disease. Neurology 63:1187-92(2004).
10. Reaven GM, Laws A. "Insulin resistance: the metabolic syndrome X" Humana Press.Totowa, New Jersey1999).
11. Pi-Sunyer FX. The Obesity Epidemic: Pathophysiology and Consequences of Obesity. Obes Res 10:97S-104(2002).
12. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss: An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 113:898-918(2006).
13. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults - The Evidence Report. National Institutes of Health [published erratum appears in Obes Res 1998 Nov;6(6):464]. Obesity Res 6:51S-209(1998).
14. Mueller WH, Wear ML, Hanis CL, Emerson JB, Barton SA, Hewett-Emmett D, et al. Which measure of body fat distribution is best for epidemiologic research? Am J Epidemiol 133:858-69(1991).
15. Baumgartner RN, Heymsfield SB, Roche AF. Human body composition and the epidemiology of chronic disease. Obes Res 3:73-95(1995).
16. Wahrenberg H, Hertel K, Leijonhufvud B-M, Persson L-G, Toft E, Arner P. Use of waist circumference to predict insulin resistance: retrospective study. BMJ 330:1363-4(2005).
17. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 79:379-84(2004).
18. Mitchell D, Haan MN, Steinberg FM, Visser M. Body composition in the elderly: the influence of nutritional factors and physical activity. J Nutr Health Aging 7:130-9(2003).
19. Visser M, Langlois J, Guralnik JM, Cauley JA, Kronmal RA, Robbins J, et al. High body fatness, but not low fat-free mass, predicts disability in older men and women: the Cardiovascular Health Study. Am J Clin Nutr 68:584-90(1998).
20. Flegal KM, Carroll MD,Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288:1723-7(2002).
21. Ford ES, Mokdad AH, Giles WH. Trends in Waist Circumference among U.S. Adults. Obes Res 11:1223-31(2003).
22. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of Overweight and Obesity Among US Children, Adolescents, and Adults, 1999-2002. JAMA 291:2847-50(2004).
23. Prevalence and trends in obesity among US adults, 1999-2000.[see comment]. JAMA 288:1723-7(2002).
24. Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL. The effect of age on the association between body-mass index and mortality. N Engl J Med:1-7(1998).
25. Stevens J, Cai J, Juhaeri, Thun MJ, Williamson DF, Wood JL. Consequences of the use of different measures of effect to determine the impact of age on the association between obesity and mortality. Am J Epidemiol 150:399-407(1999).
26. Heiat A, Vaccarino V, Krumholz HM. An Evidence-Based Assessment of Federal Guidelines for Overweight and Obesity as They Apply to Elderly Persons. Arch Intern Med 161:1194-203(2001).
27. Scarmeas N, Zarahn E, Anderson KE, Habeck CG, Hilton J, Flynn J, et al. Association of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis. Arch Neurol 60:359-65(2003).
28. Scarmeas N, Stern Y. Cognitive reserve and lifestyle. Journal of Clinical & Experimental Neuropsychology 25:625-33(2003).
29. Tang MX, Cross P, Andrews H, Jacobs DM, Small S, Bell K, et al. Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology 56:49-56(2001).
30. Morley JE. Anorexia, sarcopenia, and aging. Nutrition 17:660-3(2001).
31. Luchsinger JA. Diabetes. In: Aguirre-Molina M, C.W. M, R.E. Z, editors. Health issues in the Latino community. San Francisco: Jossey-Bass; 2001. p. 277-300.
32. Prevalence and trends in overweight in Mexican-american adults and children. Nutrition Reviews 62:S144-8(2004).
33. Luchsinger JA, Mayeux R. Dietary factors and Alzheimer's disease. Lancet Neurol 3:579-87(2004).
34. Luchsinger J, Mayeux R. Cardiovascular risk factors and Alzheimer's disease. Curr Atheroscler Rep 6:261-6(2004).
35. Luchsinger JA, Tang MX, Shea S, Mayeux R. Caloric intake and the risk of Alzheimer disease. Arch Neurol 59:1258-63(2002).
36. Larson EB, Wang L, Bowen JD, McCormick WC, Teri L, Crane P, et al. Exercise Is Associated with Reduced Risk for Incident Dementia among Persons 65 Years of Age and Older. Ann Intern Med 144:73-81(2006).
37. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735-52(2005).
38. Morgan JM, Capuzzi DM. Hypercholesterolemia. The NCEP Adult Treatment Panel III Guidelines. Geriatrics 58:33-8(2003).
39. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289:2560-72(2003).
40. Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, et al. The Effect of Metformin and Intensive Lifestyle Intervention on the Metabolic Syndrome: The Diabetes Prevention Program Randomized Trial. Ann Intern Med 142:611-9(2005).
41. Diabetes Prevention Program Research Group. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. N Engl J Med 346:393-403(2002).
42. Allison DB, Faith MS, Heo M, Kotler DP. Hypothesis concerning the U-shaped relation between body mass index and mortality. Am J Epidemiol 146:339-49(1997).
43. Kenchaiah S, Evans JC, Levy D, Wilson PWF, Benjamin EJ, Larson MG, et al. Obesity and the Risk of Heart Failure. N Engl J Med 347:305-13(2002).
44. Ansari A. Syndromes of cardiac cachexia and the cachectic heart: current perspective. Prog Cardiovas Dis 30:45-60(1987).
45. DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 133:73-4(2000).
46. ClarkJr. MJ, Sterrett JJ, Carson DS. Diabetes Guidelines: A Summary and Comparison of the Recommendations of the American Diabetes Association, Veterans Health Administration, and Ameri can Association of Clinical Endocrinologists. Clin Ther 22:899-910(2000).
47. Festa A, Williams K, D'Agostino R, Jr., Wagenknecht LE, Haffner SM. The Natural Course of {beta}-Cell Function in Nondiabetic and Diabetic Individuals: The Insulin Resistance Atherosclerosis Study. Diabetes 55:1114-20(2006).
48. Reaven G. Insulin Resistance, Type 2 Diabetes Mellitus, and Cardiovascular Disease: The End of the Beginning. Circulation 112:3030-2(2005).
49. Accili D. Lilly Lecture 2003: The Struggle for Mastery in Insulin Action: From Triumvirate to Republic. Diabetes 53:1633-42(2004).
50. Peila R, Rodriguez BL, White LR, Launer LJ. Fasting insulin and incident dementia in an elderly population of Japanese-American men. Neurology 63:228-33(2004).
51. Ferrannini E, Balkau B. Insulin: in search of a syndrome. Diabet Med 19:724-9(2002).
52. Kraja AT, Hunt SC, Pankow JS, Myers RH, Heiss G, Lewis CE, et al. An evaluation of the metabolic syndrome in the HyperGEN study. Nutr Metab (Lond) 2:2(2005).
53. Luchsinger JA, Tang MX, Shea S, Mayeux R. Hyperinsulinemia and risk of Alzheimer disease. Neurology 63:1187-92(2004).
54. Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, et al. The Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline. JAMA 292:2237-42(2004).
55. Luchsinger JA. A work in progress: the metabolic syndrome. Sci Aging Knowledge Environ 2006:pe19(2006).
56. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 348:1215-22(2003).
57. Strachan MWJ. Insulin and cognitive function. The Lancet 362:1253(2003).
58. Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 100:4162-7(2003).
59. Reger MA, Watson GS, Frey WH, 2nd, Baker LD, Cholerton B, Keeling ML, et al. Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiol Aging 27:451-8(2006).
60. Risner ME, Saunders AM, Altman JF, Ormandy GC, Craft S, Foley IM, et al. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease. Pharmacogenomics J 6:246-54(2006).
61. Kuusisto J, Koivisto K, Mykkanen L, Helkala EL, Vanhanen M, Hanninen T, et al. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study. BMJ 315:1045-9.(1997).
62. Okereke O, Hankinson SE, Hu FB, Grodstein F. Plasma C Peptide Level and Cognitive Function Among Older Women Without Diabetes Mellitus. Arch Intern Med 165:1651-6(2005).
63. Watson GS, Bernhardt T, Reger MA, Cholerton BA, Baker LD, Peskind ER, et al. Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease. Neurobiol Aging 27:38-41(2006).
64. Watson GS, Craft S. Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease. Eur J Pharmacol 490:97-113(2004).
65. Yamagishi S, Nakamura K, Inoue H, Kikuchi S, Takeuchi M. Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease. Med Hypotheses 64:1205-7(2005).
66. Trujillo ME, Scherer PE. Adiponectin - journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 257:167-75(2005).
67. Yu YH, Ginsberg HN. Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue. Circ Res 96:1042-52(2005).
68. Fewlass DC, Noboa K, Pi-Sunyer FX, Johnston JM, Yan SD, Tezapsidis N. Obesity-related leptin regulates Alzheimer's Abeta. FASEB J 18:1870-8(2004).
69. Honig LS, Tang MX, Albert S, Costa R, Luchsinger J, Manly J, et al. Stroke and the risk of Alzheimer disease. Arch Neurol 60:1707-12(2003).
70. Honig LS, Kukull W, Mayeux R. Atherosclerosis and AD: Analysis of data from the US National Alzheimer's Coordinating Center. Neurology 64:494-500(2005).
71. Sacco RL, Benjamin EJ, Broderick JP, Dyken M, Easton JD, Feinberg WM, et al. American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. Stroke 28:1507-17(1997).
72. Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, Winblad B, et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 62:1556-60(2005).
73. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP, Jr, Yaffe K. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ: bmj. 38446. 466238.E0(2005).
74. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-Year Follow-up of Overweight and Risk of Alzheimer Disease. Arch Intern Med 163:1524-8(2003).
75. Stewart R, Masaki K, Xue Q-L, Peila R, Petrovitch H, White LR, et al. A 32-Year Prospective Study of Change in Body Weight and Incident Dementia: The Honolulu-Asia Aging Study. Arch Neurol 62:55-60(2005).
76. Nourhashemi F, Deschamps V, Larrieu S, Letenneur L, Dartigues JF, Barberger-Gateau P, et al. Body mass index and incidence of dementia: the PAQUID study. Neurology 60:117-9(2003).
77. Luchsinger JA, Patel B, Tang MX, Schupf N, Mayeux R. Measures of adiposity and dementia risk in the elderly. Arch Neurol in press).
78. Morley JE, Thomas DR, Wilson M-MG. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr 83:735-43(2006).
79. White H, Pieper C, Schmader K, Fillenbaum G. Weight change in Alzheimer's disease. J Am Geriatr Soc 44:265-72(1996).
80. Wedick NM, Mayer-Davis EJ, Wingard DL, Addy CL, Barrett-Connor E. Insulin Resistance Precedes Weight Loss in Adults without Diabetes : The Rancho Bernardo Study. Am J Epidemiol 153:1199-205(2001).
81. Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R. Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 65:545-51(2005).